Open Access Oncology Journals
We understand the importance of choosing the right journal for your research.
Take the time to discover the high-impact, open access Oncology journals below and explore the different specialties that collectively comprise this portfolio.
An open access journal | 2018 Impact Factor 5.333
OncoImmunology focuses specifically on tumor immunology. As a result of recent progress in the field, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. Concurrently, there is a need for research that explores the combination of conventional anticancer therapies with immunotherapies.
OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome.
International Journal of Hyperthermia
An open access journal | 2018 Impact Factor 3.589
The International Journal of Hyperthermia is the official journal of three professional societies: the Society for Thermal Medicine (N. America), the European Society for Hyperthermic Oncology, and the Japanese Society for Thermal Medicine.
Hyperthermia provides a forum for the publication of research, perspectives and letters relating to the science, engineering, physics and clinical application of thermal energy-based disease treatment.
Submitted manuscripts will be considered for publication in one of the following categories:
- Clinical Studies: Manuscripts focused on disease treatment in clinical settings, including clinical trials and case studies that involve either human or animal patients
- Biological Studies: Manuscripts focused on biological, biochemical, anatomical or physiological studies of a basic or preclinical nature using basic biochemical, cell, animal, or computational models
- Physics and Engineering: Manuscripts devoted to the development of technologies and strategies for energy delivery and control, with an end goal to effect specific biologic responses leading to therapeutic outcomes
An open access journal | 2018 Impact Factor 4.405
mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The focus is primarily on articles of interest to scientists, clinical researchers and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.
mAbs publishes relevant and timely original research, as well as authoritative overviews, commentary and perspectives providing context for the work presented in mAbs and for key results published elsewhere. Original research papers may cover all topics important in the antibody field, including studies of targeted proteins that are not antibody-based. Reviews, commentaries and perspectives on any aspect of antibody R&D are also welcome.